Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

The outcome of patients with multiple myeloma is dictated primarily by cytogenetic abnormalities and proliferative capacity of plasma cells. We studied the outcome after initial therapy with lenalidomide-dexamethasone among 100 newly diagnosed patients, risk-stratified by genetic abnormalities and p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kapoor, Prashant, Kumar, Shaji, Fonseca, Rafael, Lacy, Martha Q., Witzig, Thomas E., Hayman, Suzanne R., Dispenzieri, Angela, Buadi, Francis, Bergsagel, P. Leif, Gertz, Morie A., Dalton, Robert J., Mikhael, Joseph R., Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Stewart, A. Keith, Kyle, Robert A., Greipp, Philip R., Rajkumar, S. Vincent
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2009
Teme:
Clinical Trials and Observations
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713462/
https://ncbi.nlm.nih.gov/pubmed/19324902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-01-202010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items